Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes.

Add to Collection

2009 Mar Observational studies S Shah, AK Das, A Kumar, AG Unnikrishnan, S Kalra… - … in therapy, 2009 - Springer 171

Full Author : ['Shah, Siddharth', 'Das, A K', 'Kumar, Ajay', 'Unnikrishnan, A G', 'Kalra, Sanjay', 'Baruah, M P', 'Ganapathi, B', 'Sahay, R K']
Journal Title : Advances in therapy
Chapter : Section3
Journal Year : 2009
Cited by : 13.0

INTRODUCTION: The IMPROVE study is an openlabel, nonrandomized, observational study aimed at determining the safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) treatment in subjects with type 2 diabetes from 11 countries. Here, we report the bas..... Read More

Keywords : ["biphasic insulin aspart treatment", "multinational observational study", "improve study", "type diabetes", "indian cohort", "baseline characteristic"]
PubMed Link : https://link.springer.com/article/10.1007/s12325-009-0006-9
Google Scholar Link : https://scholar.google.com/scholar?cites=16734691377962718857&as_sdt=800005&sciodt=0,15&hl=en&num=20

Have a Question?

Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes.